Detalles de la búsqueda
1.
The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosis.
Mult Scler
; 23(8): 1137-1147, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27758955
2.
Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.
Mult Scler
; 20(8): 1095-101, 2014 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24378984
3.
Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.
Mult Scler
; 19(5): 622-30, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23012254
4.
Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden.
Mult Scler J Exp Transl Clin
; 1: 2055217315608203, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-28607705
5.
Effect of treatment with natalizumab on ability to work in people with multiple sclerosis: productivity gain based on direct measurement of work capacity before and after 1 year of treatment.
BioDrugs
; 25(5): 299-306, 2011 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21942914
Resultados
1 -
5
de 5
1
Próxima >
>>